Adlai Nortye Ltd
F:N2U0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Adlai Nortye Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Adlai Nortye Does
Adlai Nortye Ltd. is a clinical-stage biotechnology company that develops cancer medicines, with a focus on drugs that target tumor growth signals and help the immune system attack cancer. Its work is centered on discovering, testing, and advancing experimental therapies through clinical trials rather than selling approved medicines at scale.
- Headquarters
- Cayman Islands KY
- Employees
- 109
- IPO date
- Sep 29, 2023
Ownership
Adlai Nortye insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Continue N2U0 Research
Decided on Adlai Nortye? Get an email when N2U0 reaches the price you’d buy at. Free with an account.